Business Wire

Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure

FOSTER CITY, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next ...
Seeking Alpha

Gritstone bio and Genevant Sciences Announce Option and License Agreement

EMERYVILLE, Calif., VANCOUVER, British Columbia, and BASEL, Switzerland, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (GRTS), a clinical-stage biotechnology company that aims to develop the ...
Seeking Alpha

Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

EMERYVILLE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today reported financial ...
WDAF-TV

Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA Award

VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and expansive ...
Insider Monkey

Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript

Gritstone bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. My name is Latonya and welcome to Gritstone ...